BAILLIE GIFFORD & CO 13D and 13G filings for Nanobiotix S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:11 am Sale |
2024-12-31 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 1,919,670 4.100% |
-949,360 (-33.09%) |
Filing |
| 2024-01-29 10:53 am Purchase |
2023-12-29 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 2,869,030 6.210% |
1,355,823 (+89.60%) |
Filing |
| 2023-02-02 11:30 am Sale |
2023-01-31 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 1,513,207 4.340% |
-230,919 (-13.24%) |
Filing |
| 2023-01-20 06:11 am Sale |
2022-12-30 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 1,744,126 5.001% |
-65,710 (-3.63%) |
Filing |
| 2022-01-26 07:18 am Unchanged |
2021-12-31 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 1,809,836 5.200% |
0 (Unchanged) |
Filing |
| 2021-01-27 11:58 am Purchase |
2020-12-31 | 13G | Nanobiotix S.A. NBTX |
BAILLIE GIFFORD & CO | 1,809,836 5.270% |
1,809,836 (New Position) |
Filing |